Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval

Author： Tolman Justin A   Faulkner Michele A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.18, 2009-12, pp. : 3077-3089

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The US Government Accountability Office is to review a drug approval process used by the FDA

By  

Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Debate over FDA drug approval using new `animal rule'

By  

Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rosuvastatin safety: lessons from the FDA review and post-approval surveillance

By Davidson Michael H  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 547-557

Informa Healthcare

Access to resources Recommend Favorite

Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical Implications

By  

Current Drug Targets, Vol. 19, Iss. 15, 2018-12 ,pp. : 1782-1800

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Updates on the Calcium-Sensing Receptor as a Drug Target

By  

Current Medicinal Chemistry, Vol. 15, Iss. 2, 2008-01 ,pp. : 178-186

Bentham Science Publishers

Access to resources Recommend Favorite